Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer, using its novel patented CXCL10 biomarker. Cleo’s first test – AdnexaSureTM is designed to distinguish benign from malignant growths and will…
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX: AAU, OTCQB: ANTMF) is pleased to present the attached copy…
(TheNewswire) Vancouver, British Columbia TheNewswire – February 16, 2024 – Integrated Cyber Solutions Inc . (CSE:ICS) (FSE:Y4G) (‘Integrated Cyber’…
Overview Fireweed Metals (TSXV:FWZ, OTCQB:FWEDF, FSE:M0G) is a Canadian mining exploration and development company focused on advancing the Macmillan…
Highlights Company to host a webcast and conference call to discuss 2024 exploration program on Friday, February 23 rd…
Oceana Lithium Limited (ASX: OCN) advises that Non-Executive Chairman Mr Jerome Vitale and Non-Executive Director Mr Simon Mottram have…
Cannabis company Blüm Holdings (OTCQB:BLMH) signed a letter of intent to purchase three California retail locations from Operators Only…
The S&P/TSX Venture Composite Index (INDEXTSI:JX) jumped 7.68 points this past week to close at 556.76 The latest inflation…
Kali Metals Limited (ASX: KM1) (“Kali” or “Company”) is pleased to announce that multiple lithium soil sampling anomalies have…